Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)

NCT03684278 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

290

Enrollment

OTHER

Sponsor class

Conditions

Acute Pancreatitis

Interventions

DRUG: Infusion of 5 mg/kg Infliximab
DRUG: Infusion of 10 mg/kg Infliximab
OTHER: 0.9% Sodium Chloride (Placebo)

Sponsor

University of Liverpool

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]